Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan, South Korea.
Institute of Tissue Regeneration, Soonchunhyang University, Cheonan, South Korea.
J Biomater Sci Polym Ed. 2022 Sep;33(13):1664-1684. doi: 10.1080/09205063.2022.2069398. Epub 2022 May 1.
Although the continuous development of small-diameter vascular grafts (SDVGs) ( < 5 mm) continues, most vascular grafts are made from synthetic polymers, which lead to serious complications from arteriosclerosis, thrombosis, and vascular ischemia. Here, to address these shortcomings, we combine synthetic polymers with natural decellularized small-diameter vessels and loaded with growth factor. We fabricated vascular grafts by electrospinning polycaprolactone (PCL) to decellularized rat aorta matrix (ECM) followed by heparin and vascular endothelial growth factor (VEGF) loading. studies showed that PCL/ECM/VEGF vascular grafts, showed excellent hemocompatibility and biocompatibility properties. The vascular grafts implanted into the rat aorta revealed that the PCL/ECM/VEGF grafts promotes endothelial cells and smooth-muscle cells infiltration with a rate of FLK-1, ICAM1, and a-SMA distribution higher than that of the PCL and PCL/ECM vascular grafts at 2 weeks and 4 weeks after implantation. The PCL/ECM/VEGF vascular graft should be considered for potential small-diameter vascular grafts in clinical fields.
尽管小直径血管移植物(SDVGs)(<5mm)的不断发展,但大多数血管移植物都是由合成聚合物制成的,这会导致动脉硬化、血栓形成和血管缺血等严重并发症。在这里,为了解决这些缺点,我们将合成聚合物与天然去细胞化的小直径血管结合,并加载生长因子。我们通过静电纺丝聚己内酯(PCL)来制备血管移植物,以脱细胞大鼠主动脉基质(ECM)为基础,然后负载肝素和血管内皮生长因子(VEGF)。研究表明,PCL/ECM/VEGF 血管移植物具有优异的血液相容性和生物相容性。将血管移植物植入大鼠主动脉后,结果显示 PCL/ECM/VEGF 移植物促进了内皮细胞和平滑肌细胞的浸润,在植入后 2 周和 4 周时,FLK-1、ICAM1 和 a-SMA 的分布率高于 PCL 和 PCL/ECM 血管移植物。PCL/ECM/VEGF 血管移植物有望在临床领域应用于小直径血管移植物。